- Home
- FULC vs NETD Comparison
FULC vs NETD Comparison
Compare FULC & NETD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FULC
- NETD
- Stock Information
- Founded
- FULC 2015
- NETD 2023
- Country
- FULC United States
- NETD United States
- Employees
- FULC N/A
- NETD N/A
- Industry
- FULC Biotechnology: Pharmaceutical Preparations
- NETD
- Sector
- FULC Health Care
- NETD
- Exchange
- FULC Nasdaq
- NETD Nasdaq
- Market Cap
- FULC 375.4M
- NETD 422.4M
- IPO Year
- FULC 2019
- NETD 2023
- Fundamental
- Price
- FULC $6.44
- NETD $11.22
- Analyst Decision
- FULC Buy
- NETD
- Analyst Count
- FULC 8
- NETD 0
- Target Price
- FULC $7.13
- NETD N/A
- AVG Volume (30 Days)
- FULC 984.6K
- NETD 140.2K
- Earning Date
- FULC 07-29-2025
- NETD 01-01-0001
- Dividend Yield
- FULC N/A
- NETD N/A
- EPS Growth
- FULC N/A
- NETD N/A
- EPS
- FULC N/A
- NETD 0.34
- Revenue
- FULC N/A
- NETD N/A
- Revenue This Year
- FULC N/A
- NETD N/A
- Revenue Next Year
- FULC N/A
- NETD N/A
- P/E Ratio
- FULC N/A
- NETD $33.03
- Revenue Growth
- FULC 2752.05
- NETD N/A
- 52 Week Low
- FULC $2.32
- NETD $10.58
- 52 Week High
- FULC $10.13
- NETD $11.47
- Technical
- Relative Strength Index (RSI)
- FULC 39.24
- NETD 62.00
- Support Level
- FULC $6.47
- NETD $11.20
- Resistance Level
- FULC $7.00
- NETD $11.24
- Average True Range (ATR)
- FULC 0.57
- NETD 0.05
- MACD
- FULC -0.12
- NETD 0.00
- Stochastic Oscillator
- FULC 5.42
- NETD 93.75
About FULC Fulcrum Therapeutics Inc.
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.
About NETD Nabors Energy Transition Corp. II
Nabors Energy Transition Corp II is a blank check company.